The inaugural Enhanced Games launched in Las Vegas this week, marking the first major sporting competition to explicitly encourage performance-enhancing drug use among athletes. The International Olympic Committee has condemned the event, with officials describing it as an attempt to “destroy any concept of fair play” and calling the initiative “moronic.”
Performance Enhancement Comes With Documented Health Risks
Percentage of users experiencing adverse effects from common PEDs
Source: World Anti-Doping Agency, 2025 | Georgian Medical Journal News
Medical Community Raises Safety Concerns
Sports medicine physicians have expressed serious concerns about athlete safety at the Enhanced Games. The event’s explicit promotion of performance-enhancing drug use contradicts decades of medical research documenting significant health risks associated with these substances.
According to the World Anti-Doping Agency, anabolic steroids can cause liver damage, cardiovascular complications, and hormonal disruptions. Growth hormone abuse has been linked to joint problems, diabetes, and increased cancer risk, as documented in multiple clinical studies.
The Enhanced Games organizers have not published comprehensive medical protocols for athlete monitoring, raising questions about participant safety oversight. Traditional Olympic sports maintain extensive medical surveillance systems to protect athlete health during competition.
Ethical Implications for Competitive Sport
The event has sparked debate within the global sports community about the fundamental principles of athletic competition. The International Olympic Committee maintains that fair play requires athletes to compete without artificial enhancement, a principle enshrined in the Olympic Charter since 1999.
Sports ethicists argue that the Enhanced Games model could normalize drug use among younger athletes who view professional competitors as role models. Research published in the Journal of Sports Sciences demonstrates that elite athlete behavior significantly influences amateur participation in doping practices.
The event’s commercial sponsors include several supplement companies, creating potential conflicts of interest regarding athlete welfare versus profit motives. This relationship pattern has been previously documented in other controversial sporting ventures.
Regulatory Response and Future Implications
The United States Anti-Doping Agency has stated it will not recognize any records set at the Enhanced Games for official sporting purposes. Similarly, major international sports federations have indicated that participants may face sanctions if they compete in traditional events after Enhanced Games participation.
The U.S. Food and Drug Administration has issued warnings about the medical risks of performance-enhancing substances, particularly when used outside clinical supervision. The agency’s guidance emphasizes that many substances promoted for athletic enhancement lack safety data for healthy individuals.
Legal experts suggest the Enhanced Games model could face regulatory challenges in jurisdictions with strict controls on performance-enhancing substances. The event’s long-term viability may depend on evolving international attitudes toward pharmaceutical enhancement in competitive sports, a topic gaining attention in sports governance discussions.
Athletes using anabolic steroids show 85% prevalence of adverse health effects, including cardiovascular complications and liver dysfunction, according to systematic review data.
— World Anti-Doping Agency Medical Research Division (Prohibited List Review, 2025)
Key takeaways
- Enhanced Games explicitly permit performance-enhancing drugs, breaking with traditional sporting principles
- Medical experts cite documented health risks including cardiovascular and liver complications from PED use
- IOC and major sports federations have condemned the event and may sanction participating athletes
- Event could influence amateur athlete behavior regarding doping practices
- Regulatory challenges may affect the competition’s future viability in multiple jurisdictions
Frequently asked questions
What makes the Enhanced Games different from traditional Olympic competition?
The Enhanced Games explicitly encourage and permit the use of performance-enhancing drugs, which are banned in Olympic and most professional sports. Athletes are not subject to anti-doping testing and are expected to use pharmaceutical enhancement to maximize performance.
What are the main health risks associated with performance-enhancing drugs?
According to World Anti-Doping Agency research, common risks include cardiovascular complications, liver damage, hormonal disruptions, and increased cancer risk. Anabolic steroids show adverse effects in 85% of users, while growth hormone abuse can cause diabetes and joint problems.
Will Enhanced Games records be recognized by official sports organizations?
No, major sports federations including the IOC and USADA have stated they will not recognize Enhanced Games results. Athletes participating may also face sanctions preventing them from competing in traditional sanctioned events.
The Enhanced Games represent a significant departure from established sporting principles, raising fundamental questions about the future of competitive athletics. As the event proceeds, its impact on athlete health, sporting integrity, and public attitudes toward pharmaceutical enhancement will likely influence broader discussions about the role of technology and drugs in human performance. The medical community’s ongoing research into performance-enhancing substance safety will be crucial for informing future policy decisions in this evolving landscape.
Source: The enhanced games, or ‘steroid Olympics’, are on—they pose risks for athletes and viewers
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
